PeopleBio, Inc. (KOSDAQ:304840)

Market Cap	24.46B -54.2%
Revenue (ttm)	2.87B +19.2%
Net Income	-14.90B
EPS	-681.91
Shares Out	24.26M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,675
Open	1,000.00
Previous Close	1,000.00
Day's Range	980.00 - 1,043.00
52-Week Range	600.00 - 2,970.00
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam-si, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2002
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 304840

Financial Performance

In 2025, PeopleBio's revenue was 2.85 billion, an increase of 12.64% compared to the previous year's 2.53 billion. Losses were -15.71 billion, 44.0% more than in 2024.